Literature DB >> 12581425

Long-term remodeling of a bilayered living human skin equivalent (Apligraf) grafted onto nude mice: immunolocalization of human cells and characterization of extracellular matrix.

Sylviane Guerret1, Emmanuel Govignon, Daniel J Hartmann, Vincent Ronfard.   

Abstract

Type I collagen is a clinically approved biomaterial largely used in tissue engineering. It acts as a regenerative template in which the implanted collagen is progressively degraded and replaced by new cell-synthesized tissue. Apligraf, a bioengineered living skin, is composed of a bovine collagen lattice containing living human fibroblasts overlaid with a fully differentiated epithelium made of human keratinocytes. To investigate its progressive remodeling, athymic mice were grafted and the cellular and the extracellular matrix components were studied from 0 to 365 days after grafting. Biopsies were analyzed using immunohistochemistry with species-specific antibodies and electron microscopy techniques. We observed that this bioengineered tissue provided living and bioactive cells to the wound site up to 1 year after grafting. The graft was rapidly incorporated within the host tissue and the bovine collagen present in the graft was progressively replaced by human and mouse collagens. A normal healing process was observed, i.e., type III collagen appeared transiently with type I collagen, the major collagen isoform present at later stages. New molecules, such as elastin, were produced by the living human cells contained within the graft. This animal model combined with species-specific immunohistochemistry tools is thus very useful for studying long-term tissue remodeling of bioengineered living tissues.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12581425     DOI: 10.1046/j.1524-475x.2003.11107.x

Source DB:  PubMed          Journal:  Wound Repair Regen        ISSN: 1067-1927            Impact factor:   3.617


  6 in total

Review 1.  Natural origin biodegradable systems in tissue engineering and regenerative medicine: present status and some moving trends.

Authors:  J F Mano; G A Silva; H S Azevedo; P B Malafaya; R A Sousa; S S Silva; L F Boesel; J M Oliveira; T C Santos; A P Marques; N M Neves; R L Reis
Journal:  J R Soc Interface       Date:  2007-12-22       Impact factor: 4.118

2.  Wound healing on athymic mice with engineered skin substitutes fabricated with keratinocytes harvested from an automated bioreactor.

Authors:  Balaji Kalyanaraman; Steven T Boyce
Journal:  J Surg Res       Date:  2008-04-29       Impact factor: 2.192

Review 3.  Surgical approaches to create murine models of human wound healing.

Authors:  Victor W Wong; Michael Sorkin; Jason P Glotzbach; Michael T Longaker; Geoffrey C Gurtner
Journal:  J Biomed Biotechnol       Date:  2010-12-01

4.  A humanized stromal bed is required for engraftment of isolated human primary squamous cell carcinoma cells in immunocompromised mice.

Authors:  Girish K Patel; Carole L Yee; Stuart H Yuspa; Jonathan C Vogel
Journal:  J Invest Dermatol       Date:  2011-10-06       Impact factor: 8.551

5.  Adipose-derived stem cells improve efficacy of melanocyte transplantation in animal skin.

Authors:  Won-Suk Lim; Chang-Hyun Kim; Ji-Young Kim; Byung-Rok Do; Eo Jin Kim; Ai-Young Lee
Journal:  Biomol Ther (Seoul)       Date:  2014-07       Impact factor: 4.634

6.  A xenograft animal model of human arteriovenous malformations.

Authors:  Fang Hou; Yuemeng Dai; James Y Suen; Chunyang Fan; Ali G Saad; Gresham T Richter
Journal:  Orphanet J Rare Dis       Date:  2013-12-30       Impact factor: 4.123

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.